(Q41028782)

English

Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice

scientific article published on July 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

1 reference

based on heuristic

inferred from title

author name string

A Sasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

K Kitamura

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

R E Alcalde

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

T Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

A Suzuki

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Y Etoh

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

T Matsumura

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

279-285

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

New bisphosphonates in the treatment of bone metastases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Mechanisms of osteolytic bone destruction

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Mechanisms of bone destruction in the development of skeletal metastases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Metastatic bone disease: clinical and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Metastatic carcinoma in association with Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Structural requirements for bisphosphonate actions in vitro

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

The comparison of several dose levels with a zero dose control

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C279%3A%3AAID-IJC18%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19980717)77:2<279::AID-IJC18>3.0.CO;2-6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41028782&oldid=2093338189"